Vaccines

Vaccines

Harnessing Artificial Intelligence for Zero-Dose Children: A Step Towards Global Health Equity

Researchers have identified a crucial role for artificial intelligence in addressing the challenge of zero-dose children, particularly in low- and middle-income countries where vulnerable children have limited access to immunizations. The study highlights how AI can enhance routine childhood immunization by identifying zero-dose populations, optimizing vaccine delivery, and supporting data-driven

Vaccines

mRNA Vaccine-Based Cancer Immunotherapy Shows Promise with Engineered Splenic Vaccine

Researchers at the First Affiliated Hospital of Zhengzhou University have engineered a spleen-selective mRNA-LNPs vaccine that reduces inflammation while maintaining cellular immunity, offering a promising strategy for cancer immunotherapy. This innovative design principle may redefine the development of mRNA vaccines for cancer treatment. The engineered vaccine achieved superior mRNA translation